Bryce DK - Search Results

1

5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonists.

Lowe JA 3rd, Hageman DL, Drozda SE, McLean S, Bryce DK, Crawford RT, Zorn S, Morrone J, Bordner J. Lowe JA 3rd, et al. Among authors: bryce dk. J Med Chem. 1994 Oct 28;37(22):3789-811. doi: 10.1021/jm00048a015. J Med Chem. 1994. PMID: 7966138

2

Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog.

Fossa AA, DePasquale MJ, Morrone J, Zorn SH, Bryce D, Lowe JA, McLean S. Fossa AA, et al. J Pharmacol Exp Ther. 1997 Apr;281(1):180-7. J Pharmacol Exp Ther. 1997. PMID: 9103496

3

The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst.

Lowe JA 3rd, Drozda SE, Snider RM, Longo KP, Zorn SH, Morrone J, Jackson ER, McLean S, Bryce DK, Bordner J, et al. Lowe JA 3rd, et al. Among authors: bryce dk. J Med Chem. 1992 Jul 10;35(14):2591-600. doi: 10.1021/jm00092a009. J Med Chem. 1992. PMID: 1378901

4

Aza-tricyclic substance P antagonists.

Lowe JA 3rd, Drozda SE, McLean S, Bryce DK, Crawford RT, Snider RM, Longo KP, Nagahisa A, Tsuchiya M. Lowe JA 3rd, et al. Among authors: bryce dk. J Med Chem. 1994 Sep 2;37(18):2831-40. doi: 10.1021/jm00044a002. J Med Chem. 1994. PMID: 7520943

5

Design of novel cholecystokinin-B receptor ligands based on the 'double-ring system' approach.

Lowe JA 3rd, Qian W, McLean S, Bryce DK, Crawford RT, Olsson LC, Bordner J. Lowe JA 3rd, et al. Among authors: bryce dk. Regul Pept. 1996 Aug 27;65(1):11-4. doi: 10.1016/0167-0115(96)00066-3. Regul Pept. 1996. PMID: 8876030

6

Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonist.

Rosen TJ, Coffman KJ, McLean S, Crawford RT, Bryce DK, Gohda Y, Tsuchiya M, Nagahisa A, Nakane M, Lowe JA 3rd. Rosen TJ, et al. Among authors: bryce dk. Bioorg Med Chem Lett. 1998 Feb 3;8(3):281-4. doi: 10.1016/s0960-894x(98)00012-2. Bioorg Med Chem Lett. 1998. PMID: 9871670

7

Biaryl piperidines as potent and selective delta opioid receptor ligands.

Liras S, McHardy SF, Allen MP, Segelstein BE, Heck SD, Bryce DK, Schmidt AW, Vanase-Frawley M, Callegari E, McLean S. Liras S, et al. Among authors: bryce dk. Bioorg Med Chem Lett. 2010 Jan 15;20(2):503-7. doi: 10.1016/j.bmcl.2009.11.113. Epub 2009 Nov 26. Bioorg Med Chem Lett. 2010. PMID: 20015649

8

Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazole.

Rosen T, Seeger TF, McLean S, Nagel AA, Ives JL, Guarino KJ, Bryce D, Furman J, Roth RW, Chalabi PM, et al. Rosen T, et al. J Med Chem. 1990 Nov;33(11):3020-3. doi: 10.1021/jm00173a017. J Med Chem. 1990. PMID: 2231600

9

Synthesis, in vitro binding profile, and autoradiographic analysis of [3H]-cis-3-[(2-methoxybenzyl)amino]-2-phenylpiperidine, a highly potent and selective nonpeptide substance P receptor antagonist radioligand.

Rosen T, Seeger TF, McLean S, Desai MC, Guarino KJ, Bryce D, Pratt K, Heym J, Chalabi PM, Windels JH, et al. Rosen T, et al. J Med Chem. 1993 Oct 15;36(21):3197-201. doi: 10.1021/jm00073a022. J Med Chem. 1993. PMID: 7693945

10

Discovery of CP-96,345 and its characterization in disease models involving substance P.

Lowe JA 3rd, Drozda SE, Snider RM, Longo KP, Zorn SH, Jackson ER, Morrone J, McLean S, Bryce DK, Bordner J, et al. Lowe JA 3rd, et al. Among authors: bryce dk. Regul Pept. 1993 Jul 2;46(1-2):20-3. doi: 10.1016/0167-0115(93)90006-t. Regul Pept. 1993. PMID: 7692490 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page